Find Clinical Trial

Safety, Tolerability and Pharmacokinetics of S 95010 After Single Escalating Intravenous Doses in Young Healthy Male Subjects. A Randomised, Doubleblind, Placebo-controlled, Monocentre, First-In-Human Study


← Back
Study Phase Phase 1
Therapeutic Area Cardiovascular
Active Substance S095010
SponsorInstitut de Recherches Internationales Servier (I.R.I.S)
Active Substance CodeS095010
Protocol CodeCL1-95010-001
EudraCT Code2017-004180-12
NCT CodeNCT03494712


Documents and links

Results are not yet available.




Servier Glossary of Terms

To ease the reading, we are developing a glossary of terms. In this glossary, we provide the lay terms used in our lay summaries and the corresponding medical terms. You will find the Servier Glossary of Terms on this link.



© 2017 LES LABORATOIRES SERVIER, an incorporated company of Servier.
All Rights Reserved. Servier does not sell its products over the Internet.
More information

Report a side-effect with a drug.